139 filings
Page 5 of 7
8-K
420n1d
10 Nov 21
Athira Pharma Reports Third Quarter 2021 Financial Results and Business Update
4:11pm
8-K
9l0i43 r5m6u7
21 Oct 21
Departure of Directors or Certain Officers
4:09pm
8-K
5174zx67sf5 r0ow
16 Aug 21
Athira Pharma Reports Second Quarter 2021 Financial Results and Business Update
4:11pm
8-K
9hljjelx22xn7a a0k
9 Aug 21
Other Events
6:06am
8-K
7a61c5
17 Jun 21
Departure of Directors or Certain Officers
9:32pm
8-K
u73ubae
1 Jun 21
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
qzogu qdgi
13 May 21
Athira Pharma Reports First Quarter 2021 Financial Results and Provides Business Highlights
4:10pm
DEFA14A
9c2ysv6a 4ljbqjduk
16 Apr 21
Additional proxy soliciting materials
6:30am
DEF 14A
d1vf2
16 Apr 21
Definitive proxy
6:02am
S-8
qkdeyky 29j7b0wv
26 Mar 21
Registration of securities for employees
12:00am
8-K
mwxbz2he8zg0q096689
25 Mar 21
Athira Pharma Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Highlights
12:00am
10-K
qydl2
25 Mar 21
Annual report
12:00am
8-K
0yrunc vs6o7yku
8 Mar 21
Athira Pharma Announces Appointment of Barbara Kosacz
7:05am
EFFECT
pnn6g
21 Jan 21
Notice of effectiveness
12:16am
424B4
qlb2jhndxwt
21 Jan 21
Prospectus supplement with pricing info
12:00am
CORRESP
r5ycj5e
15 Jan 21
Correspondence with SEC
12:00am
CORRESP
b8e9kdh 2au
15 Jan 21
Correspondence with SEC
12:00am